You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cisplatin hypersensitivity

Showing 1 - 25 of 3,231
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Trabectedin/Caelyx vs Cisplatin Hypersensitivity in Relapsed

Completed
  • Ovarian Neoplasm
  • +4 more
    • (no location specified)
    Aug 22, 2022

    Combining Genomics and Imageomics to Predict Sensitivity of

    Not yet recruiting
    • Sensitivity
    • Neoadjuvant pemetrexed and cisplatin chemotherapy
    • (no location specified)
    Jan 5, 2022

    Platinum-Sensitive Biliary Tract Cancer Trial (Cisplatin, Gemcitabine, Oxaliplatin)

    Withdrawn
    • Platinum-Sensitive Biliary Tract Cancer
    • (no location specified)
    May 27, 2022

    Tumor Neck Trial in Shanghai (docetaxel, cisplatin and 5-fluorouracil)

    Recruiting
    • Neoplasm Neck
    • docetaxel, cisplatin and 5-fluorouracil
    • Shanghai, Shanghai, China
      Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong
    Oct 5, 2022

    Mouth Tumors, Carcinoma, Squamous Cell Trial in Shanghai (drug, procedure, radiation)

    Recruiting
    • Mouth Neoplasms
    • Carcinoma, Squamous Cell
    • TPF induction chemotherapy
    • +2 more
    • Shanghai, Shanghai, China
      Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong
    Oct 5, 2022

    Malignant Pleural Mesothelioma Trial in Worldwide (MORAb-009 (Amatuximab), Pemetrexed, Cisplatin)

    Completed
    Has Results
    • Malignant Pleural Mesothelioma
    • MORAb-009 (Amatuximab)
    • +2 more
    • Birmingham, Alabama
    • +27 more
    Aug 24, 2022

    Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer Trial in Worldwide (Ramucirumab, Merestinib, Cisplatin)

    Active, not recruiting
    Has Results
    • Biliary Tract Cancer
    • +2 more
    • Tucson, Arizona
    • +91 more
    Oct 18, 2022

    Bladder Cancer Trial in Worldwide (Gemcitabine, E7389, Cisplatin)

    Terminated
    Has Results
    • Bladder Cancer
    • Birmingham, Alabama
    • +41 more
    Feb 3, 2022

    Extranodal NK/T-cell Lymphoma Trial in Bangkok (B-MAD chemo)

    Active, not recruiting
    • Extranodal NK/T-cell Lymphoma
    • B-MAD chemotherapy
    • Bangkok, Thailand
      King Chulalongkorn Memorial Hospital
    May 7, 2022

    Bladder Cancer Trial in Worldwide (Atezolizumab)

    Active, not recruiting
    Has Results
    • Bladder Cancer
    • Birmingham, Alabama
    • +76 more
    Dec 6, 2022

    Malignant Pleural Mesothelioma, Solid Tumors Trial in United States (pemetrexed, cisplatin and CBP501, pemetrexed and cisplatin,

    Completed
    Has Results
    • Malignant Pleural Mesothelioma
    • Solid Tumors
    • pemetrexed, cisplatin and CBP501
    • +2 more
    • Scottsdale, Arizona
    • +11 more
    Jun 30, 2021

    Non-Squamous NSCLC, Squamous NSCLC Trial in Worldwide (Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody,

    Completed
    Has Results
    • Non-Squamous Non-Small Cell Lung Cancer, Squamous Non-Small Cell Lung Cancer
    • Atezolizumab (MPDL3280A) [TECENTRIQ], an engineered anti-PDL1 antibody
    • +4 more
    • La Jolla, California
    • +141 more
    Apr 21, 2022

    Non Small Cell Lung Cancer Trial in Worldwide (Necitumumab, Gemcitabine, Cisplatin)

    Active, not recruiting
    Has Results
    • Non Small Cell Lung Cancer
    • Necitumumab
    • +2 more
    • Chandler, Arizona
    • +181 more
    Feb 4, 2022

    Dermal Hypersensitivity Reaction Trial in Ann Arbor (Dupilumab)

    Not yet recruiting
    • Dermal Hypersensitivity Reaction
    • Ann Arbor, Michigan
      University of Michigan
    Aug 21, 2023

    Dentin Sensitivity Trial in Peshawar (Self etch dentin adhesive, Fluoride varnish)

    Not yet recruiting
    • Dentin Sensitivity
    • Self etch dentin adhesive, Fluoride varnish
    • Peshawar, Khyber Pakhtunkhwa, Pakistan
      Peshawar Dental College
    Jun 7, 2023

    Biliary Tract Cancer Trial in Worldwide (Durvalumab, Gemcitabine monotherapy, Gemcitabine + cisplatin)

    Not yet recruiting
    • Biliary Tract Cancer
    • Durvalumab
    • +7 more
    • Orange, California
    • +36 more
    Mar 6, 2023

    Tumor Trial in Worldwide (PF-05212384 (gedatolisib), Docetaxel, Cisplatin)

    Completed
    Has Results
    • Neoplasm
    • PF-05212384 (gedatolisib)
    • +3 more
    • Birmingham, Alabama
    • +28 more
    Sep 9, 2021

    Dentin Sensitivity Trial in L'Aquila (Gas ozone, Diode laser and desensitized gel)

    Completed
    • Dentin Sensitivity
    • Gas ozone
    • Diode laser and desensitized gel
    • L'Aquila, AQ, Italy
      University of L'Aquila
    May 9, 2023

    Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Ramucirumab, Capecitabine,

    Completed
    Has Results
    • Metastatic Gastric Adenocarcinoma
    • Gastroesophageal Junction Adenocarcinoma
    • Fayetteville, Arkansas
    • +134 more
    Jul 29, 2021

    Mouth Tumors, Carcinoma, Squamous Cell Trial in Shanghai (drug, procedure, radiation)

    Recruiting
    • Mouth Neoplasms
    • Carcinoma, Squamous Cell
    • TPF group
    • +2 more
    • Shanghai, Shanghai, China
      Ninth People's Hospital, Shanghai Jiao Tong University School of
    Oct 5, 2022

    Dentin Hypersensitivity Trial in Cairo (Giomer Varnish, CPP-ACP varnish)

    Recruiting
    • Dentin Hypersensitivity
    • Giomer Varnish
    • CPP-ACP varnish
    • Cairo, Egypt
      Faculty of Dentistry
    Nov 24, 2023

    Dentin Hypersensitivity Trial in Cairo (Egg Shell nanoparticles)

    Completed
    • Dentin Hypersensitivity
    • Egg Shell nanoparticles
    • Cairo, Egypt
      Faculty of Dentistary - Al-Azhar University
    Aug 29, 2023

    Recurrent Uterine Corpus Carcinoma, Stage IIIA Uterine Corpus Cancer AJCC v7, Stage IIIB Uterine Corpus Cancer AJCC v7 Trial in

    Completed
    Has Results
    • Recurrent Uterine Corpus Carcinoma
    • +5 more
    • Birmingham, Alabama
    • +649 more
    Sep 28, 2021

    Squamous Cell Carcinoma of the Head and Neck Trial in Worldwide (biological, drug, radiation)

    Completed
    Has Results
    • Squamous Cell Carcinoma of the Head and Neck
    • Nivolumab
    • +3 more
    • Anniston, Alabama
    • +54 more
    Aug 5, 2021

    Mouth Tumors, Carcinoma, Squamous Cell Trial in Shanghai (drug, procedure, radiation)

    Recruiting
    • Mouth Neoplasms
    • Carcinoma, Squamous Cell
    • TPF induction chemotherapy
    • +2 more
    • Shanghai, Shanghai, China
      Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong
    Oct 5, 2022